Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.
Sinopia Biosciences has raised $400K in total funding. The most recent round was Grant. The last funding was announced in March 2026.
Sinopia Biosciences's investors include Michael J. Fox Foundation, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Heart, Lung and Blood Institute, National Institute of General Medical Science.
Sinopia Biosciences is headquartered in San Diego, United States.
Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.
Sinopia Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sinopia Biosciences — Funding & Investors." VCBacked, March 24, 2026, https://www.vcbacked.co/company/sinopia-biosciences. Accessed November 13, 2026.
VCBacked. (2026). Sinopia Biosciences — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/sinopia-biosciences
{{cite web |title=Sinopia Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/sinopia-biosciences |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Sinopia Biosciences? Request a listing update